Difference between revisions of "Loricrin (TG1)"

From MyMediaWiki
Jump to: navigation, search
m
m
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''  
+
! {infobox header}| '''{{PAGENAME}}'''  
|-
 
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
 
 
|-
 
|-
 
| Substrate peptide name
 
| Substrate peptide name
Line 57: Line 55:
 
|  
 
|  
 
|-
 
|-
| {{infobox header}} |  
+
| {infobox header} |  
 
|-
 
|-
 
|}
 
|}
  
 
[[Category:Keratinocyte transglutaminase|*]]
 
[[Category:Keratinocyte transglutaminase|*]]

Latest revision as of 11:18, 10 March 2015

Loricrin (TG1)
Substrate peptide name Loricrin
Synonyms -
Determination type In situ
Source Homo sapiens
Subcellular localization Cornified envelope
Swissprot ID P23490
Reactive glutamines Q3, Q6, Q10, Q153, Q156, Q215, Q216, Q219, Q225, Q303, Q305, Q306, Q308
Reactive lysines K4, K5, K88, K307, K315
Substrate sequence SYQKKQPTPQPPV

SGGSVKYSGGG

FSGQAVQCQSY

YVSSQQVTQTSCA

APQPSYGGG

CHQTQQKQAPTWPSK

Structure No available crystal structure
Surface accessibility
Disorder prediction IUPred
Reference PMID:2007607

PMID:7543090

Notes